参考文献/References:
[1]von der Recke G,Schmidt H,Illien S,et al. Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients with atrial fibrillation before cardioversion[J]. J Am Soc Echocardiogr,2002,15(10 Pt 2): 1256-1261.
[2]Bernier M,Abdelmoneim SS,Stuart Moir W,et al. CUTE-CV:a prospective study of enhanced left atrial appendage visualization with microbubble contrast agent use during transesophageal echocardiography guided cardioversion[J]. Echocardiography,2013,30(9):1091-1097.
[3]Shiyovich A,Khalameizer V,Katz A. New treatments for stroke and thromboembolism prevention in atrial fibrillation[J]. Harefuah,2014,153(1):32-38,64.
[4]Bernhardt P,Schmidt H,Hammerstingl C,et al. Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging[J]. J Am Coll Cardiol,2005,45(11):1807-1812.
[5]Ernst E,Resch KL. Fibrinogen as a cardiovascular risk factor:a meta-analysis and review of the literature[J]. Ann Intern Med,1993,118(12):956-963.
[6]Black IW,Chesterman CN,Hopkins AP,et al. Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation [J]. J Am Coll Cardiol,1993,21(2):451-457.
[7]Hajjiri M,Bernstein S,Saric M,et al. Atrial fibrillation ablation in patients with known sludge in the left atrial appendage[J]. J Interv Card Electrophysiol,2014,40(2):147-151.
[8]Yoo J,Song D,Baek JH,et al. Poor outcome of stroke patients with atrial fibrillation in the presence of coexisting spontaneous echo contrast[J]. Stroke,2016,47(7):1920-1922.
[9]di Biase L,Santangeli P,Anselmino M,et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation?Results from a multicenter study[J]. J Am Coll Cardiol,2012,60(6): 531-538.
[10]Petersen M,Roehrich At,Balzer J,et al. Left atrial appendage morphology is closely associated with specific echocardiographic flow pattern in patients with atrial fibrillation[J]. Europace,2015,17(4):539-545.
[11]Wang F,Zhu M,Wang X,et al. Predictive value of left atrial appendage lobes on left atrial thrombus or spontaneous echo contrast in patients with non-valvular atrial fibrillation[J]. BMC Cardiovasc Disord,2018,18(1):153.
[12]孙兰兰,李一丹,王丽,等. 非瓣膜性心房颤动患者左心耳自发显影或血栓形成影响因素的临床研究[J]. 中华超声影像学杂志,2017,26(4):282-286.
[13] Lowe BS,Kusunose K,Motoki H,et al. Prognostic significance of left atrial appendage“sludge”in patients with atrial fibrillation:a new transesophageal echocardiographic thromboembolic risk factor[J]. J Am Soc Echocardiogr, 2014,27(11):1176-1183.
[14] Ito T,Suwa M,Kobashi A,et al. Integrated backscatter assessment of left atrial spontaneous echo contrast in chronic nonvalvular atrial fibrillation:relation with clinical and echocardiographic parameters[J]. J Am Soc Echocardiogr,2000,13(7): 666-673.
[15] Ohno Y,Attizzani GF,Capodanno D,et al. Acute left atrial spontaneous echocardiographic contrast and suspicious thrombus formation following mitral regurgitation reduction with the MitraClip system[J]. JACC Cardiovasc Interv, 2014,7(11):1322-1323.
[16] Zhang E,Liu T,Li Z,et al. High CHA2DS2-VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography[J]. Int J Cardiol,2015,184:540-542.
[17] Topaz G,Pereg D,Shuvy M,et al. Pre-admission CHA2DS2-VASc score and outcome of patients with acute cerebrovascular events[J]. Int J Cardiol, 2017,244:277-281.
[18] Liu T,Shao Q,Korantzopoulos P,et al. Relation of red blood cell distribution width with CHADS and CHADS-VASc score in Chinese patients with non-valvular atrial fibrillation[J]. Int J Cardiol,2017,228:861-864.
[19] Han D,Chu Y,Wu Y,et al. Determinants of left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation[J]. Thromb Res,2020,195: 233-237.
[20] Kuang RR,Liu FZ,Li YP,et al. Hemoglobin A1c and risk of left atrial thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients[J]. Eur J Med Res,2017,22(1):15.
[21] Liu FZ,Liao HT,Lin WD,et al. Predictive effect of hyperuricemia on left atrial stasis in non-valvular atrial fibrillation patients[J]. Int J Cardiol,2018,258: 103-108.
[22] Black IW. Spontaneous echo contrast:where there’s smoke there’s fire[J]. Echocardiography,2000,17(4):373-382.
[23] Turchetti V,Bellini MA,Ricci D,et al. Spontaneous echo-contrast as an in vivo indicator of rheological imbalance in dilatative cardiomyopathy[J]. Clin Hemorheol Microcirc,2001,25(3-4):119-125.
[24] Zotz RJ,Müller M,Genth-Zotz S,et al. Spontaneous echo contrast caused by platelet and leukocyte aggregates?[J]. Stroke,2001,32(5):1127-1133.
[25] Han D,Chu Y,Wu Y,et al. Determinants of left atrial thrombus or spontaneous echo contrast in nonvalvular atrial fibrillation[J]. Thromb Res,2020,195: 233-237.
[26]Wan H,Wu S,Yang Y,et al. Plasma fibrin D-dimer and the risk of left atrial thrombus:a systematic review and meta-analysis[J]. PLoS One,2017,12(2): e0172272.
[27] Yashiro Y,Arimoto T,Hashimoto N,et al. Predictors of left atrial coagulation activity among paroxysmal atrial fibrillation patients[J]. Circ J,2015, 79(1):61-69.
[28] Ioannou A,Papageorgiou N,Falconer D,et al. Biomarkers associated with stroke risk in atrial fibrillation[J]. Curr Med Chem,2019,26(5): 803-823.
[29] Kocyigit D,Gurses KM,Yalcin MU,et al. Serum galectin-3 level as a marker of thrombogenicity in atrial fibrillation[J]. J Clin Lab Anal,2017,31(6):22120.
[30] Klein AL,Murray RD,Black IW,et al. Integrated backscatter for quantification of left atrial spontaneous echo contrast[J]. J Am Coll Cardiol,1996,28(1):222-231.
[31] 花霞,孙志英,王少波,等. 左房自发性显影的定量及分级预测房颤患者并发卒中的临床分析[J]. 医学影像学杂志,2015,25(4):706-709.
[32] Posada-Martinez EL,Trejo-Paredes C,Ortiz-Leon XA,et al. Differentiating spontaneous echo contrast,sludge,and thrombus in the left atrial appendage:can ultrasound enhancing agents help?[J]. Echocardiography,2019,36(7):1413-1417.